Cargando…
Human placenta mesenchymal stem cell protection in ischemic stroke is angiotensin converting enzyme‐2 and masR receptor‐dependent
Thromboembolic stroke remains a major cause of neurological disability and death. Current stroke treatments (aspirin, tissue plasminogen activator) are significantly limited by timing and risks for hemorrhage which have driven researchers to explore other approaches. Stem cell‐based therapy appears...
Autores principales: | Barzegar, Mansoureh, Vital, Shantel, Stokes, Karen Y., Wang, Yuping, Yun, Jungmi Winny, White, Luke A., Chernyshev, Oleg, Kelley, Roger E., Alexander, Jonathan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881785/ https://www.ncbi.nlm.nih.gov/pubmed/34124808 http://dx.doi.org/10.1002/stem.3426 |
Ejemplares similares
-
The Role of the ACE2/MasR Axis in Ischemic Stroke: New Insights for Therapy
por: Barzegar, Mansoureh, et al.
Publicado: (2021) -
Sex Difference in MasR Expression and Functions in the Renal System
por: Choopani, Samira, et al.
Publicado: (2022) -
Angiotensin-(1-7)/MasR axis promotes migration of monocytes/macrophages with a regulatory phenotype to perform phagocytosis and efferocytosis
por: Zaidan, Isabella, et al.
Publicado: (2022) -
Human placental mesenchymal stem cells improve stroke outcomes via extracellular vesicles-mediated preservation of cerebral blood flow
por: Barzegar, Mansoureh, et al.
Publicado: (2020) -
Involvement of the ACE2/Ang-(1–7)/MasR Axis in Pulmonary Fibrosis: Implications for COVID-19
por: Morganstein, Taylor, et al.
Publicado: (2021)